Aims To investigate optic nerve head (ONH) parameters in highly myopic individuals with open-angle glaucoma (OAG) and their ...

A deep-learning model trained on optical coherence tomography scans of the optic nerve head reliably distinguished among various types of optic nerve damage, such as glaucoma, non-arteritic anterior ...

New research links two widely used diabetes drugs, semaglutide or tirzepatide, to a rare but potentially vision-threatening eye condition, raising questions about drug-specific risks and the need for ...

A large-scale cohort study has found that GLP-1s, including Ozempic and Wegovy, may be associated with a modestly increased risk of developing diabetic retinopathy. The research, published Aug. 11 in ...

A retrospective cohort study suggested that users of GLP-1 receptor agonists had a 7% higher incidence of new-onset diabetic retinopathy. In patients with existing diabetic retinopathy, use of GLP-1 ...

As a medical student, I have had the opportunity to join the iMIND lab at Duke University and contribute to the growing and captivating neuro-ophthalmology field, which expands our understanding of ...

PHOENIX — Historically, optic nerve involvement has been excluded from multiple sclerosis (MS) diagnostic criteria, but its inclusion in the upcoming 2024 McDonald Diagnostic Criteria is expected to ...

At ARVO 2025, in Salt Lake City, Utah, Danielle Gauthier talked about her poster on autosomal dominant Alzheimer disease in relation to optic nerve head drusen. At ARVO 2025, in Salt Lake City, Utah, ...

One of the world's leading causes of irreversible vision loss could begin with elevated eye pressure, according to a recent study. One of the world's leading causes of irreversible vision loss could ...

One of the world’s leading causes of irreversible vision loss could begin with elevated eye pressure, according to a recent study published in the American Academy of Ophthalmology. “We wanted to see ...

A vitamin supplement that improves metabolism in the eye appears to slow down damage to the optic nerve in glaucoma. The researchers behind the study have now started a clinical trial on patients. A ...